We narrowed to 9,664 results for: CAR
-
Plasmid#22495DepositorHas service50 µg Transfection-Ready DNA and 100 µg Transfection-Ready DNAInsertADE1 (ADE1 Budding Yeast)
UseYeast shuttleMutationOriginal 4067 bp HindIII-HindIII insertion (see Y…Available sinceJan. 20, 2010AvailabilityAcademic Institutions and Nonprofits only -
pHR-mCherry-p2A-full length LIC1
Plasmid#74601Purposeexpresses LIC1 in mammalian cells; untagged but cells indicate expression with diffuse mCherryDepositorInsertfull length human dynein light intermediate chain 1 (DYNC1LI1 Human)
UseLentiviralExpressionMammalianPromoterSFFVAvailable sinceJuly 6, 2016AvailabilityAcademic Institutions and Nonprofits only -
tetO-FUW-eGFP-RHOA-T19N
Plasmid#73082PurposeLentiviral transfer vector for tet-inducible expression of EGFP tagged human RHOA-T19NDepositorAvailable sinceFeb. 24, 2016AvailabilityAcademic Institutions and Nonprofits only -
lentiCRISPR v2-sgSLC7A11/xCT-2
Plasmid#161819Purposeknock out SLC7A11/xCT in mammalian cellsDepositorInsertsolute carrier family 7 member 11 (SLC7A11 Human)
UseCRISPR and LentiviralAvailable sinceDec. 8, 2020AvailabilityAcademic Institutions and Nonprofits only -
Tet-myr-GFP
Plasmid#83468PurposeLentiviral vector for doxycycline-inducible expression of membrane targeted-GFP in mammalian cellsDepositorInsertMyristoylated GFP
UseLentiviralExpressionMammalianPromoterdoxycycline-inducible promoterAvailable sinceOct. 6, 2016AvailabilityAcademic Institutions and Nonprofits onlyCited by -
pcDNA3-RAGEdeltaCyto
Plasmid#71436Purposemammalian expression of human RAGE cytoplasmic domain mutantDepositorHas service50 µg Transfection-Ready DNA and 100 µg Transfection-Ready DNAInsertRAGE (AGER Human)
ExpressionMammalianMutationdelta 367-404PromoterCMVAvailable sinceNov. 25, 2015AvailabilityAcademic Institutions and Nonprofits onlyCited by -
pAAV_hSyn_WiChR_TS_mScarlet_ER (AAV9)
Viral prep#205997-AAV9PurposeReady-to-use AAV9 particles produced from pAAV_hSyn_WiChR_TS_mScarlet_ER (#205997). In addition to the viral particles, you will also receive purified pAAV_hSyn_WiChR_TS_mScarlet_ER plasmid DNA. hSyn-driven K+ selective channelrhodopsin for optogenetic inhibition of neurons. These AAV preparations are suitable purity for injection into animals.DepositorPublicationPromoterSynTagsmScarletAvailable sinceJuly 30, 2025AvailabilityAcademic Institutions and Nonprofits only -
pAAV-hSyn-Kir2.1Mut-2A-mScarlet-KASH (AAV2)
Viral prep#203841-AAV2PurposeReady-to-use AAV2 particles produced from pAAV-hSyn-Kir2.1Mut-2A-mScarlet-KASH (#203841). In addition to the viral particles, you will also receive purified pAAV-hSyn-Kir2.1Mut-2A-mScarlet-KASH plasmid DNA. hSyn-driven expression of mutant murine Kir2.1 and mScarlet-KASH. These AAV preparations are suitable purity for injection into animals.DepositorAvailable sinceFeb. 9, 2026AvailabilityAcademic Institutions and Nonprofits only -
pAAV-hSyn-Kir2.1WT-2A-mScarlet-KASH (AAV8)
Viral prep#203840-AAV8PurposeReady-to-use AAV8 particles produced from pAAV-hSyn-Kir2.1WT-2A-mScarlet-KASH (#203840). In addition to the viral particles, you will also receive purified pAAV-hSyn-Kir2.1WT-2A-mScarlet-KASH plasmid DNA. hSyn-driven expression of Kir2.1 and mScarlet-KASH. These AAV preparations are suitable purity for injection into animals.DepositorTagsmScarlettAvailable sinceOct. 8, 2025AvailabilityAcademic Institutions and Nonprofits only -
pAAV_EF1a-DIO-PdCO-mScarlet-ER-miniWPRE (AAV1)
Viral prep#198516-AAV1PurposeReady-to-use AAV1 particles produced from pAAV_EF1a-DIO-PdCO-mScarlet-ER-miniWPRE (#198516). In addition to the viral particles, you will also receive purified pAAV_EF1a-DIO-PdCO-mScarlet-ER-miniWPRE plasmid DNA. Ef1a-driven, Cre-dependent expression of the optimized opsin PdCO in frame with mScarlet. These AAV preparations are suitable purity for injection into animals.DepositorPromoterEF-1aTagsmScarletAvailable sinceApril 10, 2024AvailabilityAcademic Institutions and Nonprofits only -
pAAV-CaMKIIa-ChRmine-oScarlet-KV 2.1-WPRE (AAV8)
Viral prep#183519-AAV8PurposeReady-to-use AAV8 particles produced from pAAV-CaMKIIa-ChRmine-oScarlet-KV 2.1-WPRE (#183519). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-ChRmine-oScarlet-KV 2.1-WPRE plasmid DNA. CaMKIIa-driven expression of ChRmine-oScarlet-KV 2.1. These AAV preparations are suitable purity for injection into animals.DepositorPromoterCaMKIIAvailable sinceDec. 18, 2024AvailabilityAcademic Institutions and Nonprofits only -
pAAV_hSyn-PdCO-mScarlet-WPRE (AAV5)
Viral prep#198510-AAV5PurposeReady-to-use AAV5 particles produced from pAAV_hSyn-PdCO-mScarlet-WPRE (#198510). In addition to the viral particles, you will also receive purified pAAV_hSyn-PdCO-mScarlet-WPRE plasmid DNA. Syn-driven expression of optimized PdCO in frame with mScarlet. These AAV preparations are suitable purity for injection into animals.DepositorPromoterSynTagsmScarletAvailable sinceSept. 27, 2024AvailabilityAcademic Institutions and Nonprofits only -
pAAV-hSyn-Kir2.1WT-2A-mScarlet-KASH (AAV2)
Viral prep#203840-AAV2PurposeReady-to-use AAV2 particles produced from pAAV-hSyn-Kir2.1WT-2A-mScarlet-KASH (#203840). In addition to the viral particles, you will also receive purified pAAV-hSyn-Kir2.1WT-2A-mScarlet-KASH plasmid DNA. hSyn-driven expression of Kir2.1 and mScarlet-KASH. These AAV preparations are suitable purity for injection into animals.DepositorTagsmScarlettAvailable sinceFeb. 6, 2026AvailabilityAcademic Institutions and Nonprofits only -
Antibody#180087-rAbPurposeAnti-VGlut1 (Rat) recombinant mouse monoclonal antibodyDepositorRecommended applicationsImmunohistochemistry and Western BlotReactivityHuman, Mouse, and RatSource speciesMouseIsotypeIgG2aTrial sizeAvailable to purchaseAvailable sinceMarch 30, 2022AvailabilityIndustry, Academic Institutions, and NonprofitsCited by
-
pAAV-CaMKIIa(0.4)-eOPN3-mScarlet-WPRE (AAV Retrograde)
Viral prep#125712-AAVrgPurposeReady-to-use AAV Retrograde particles produced from pAAV-CaMKIIa(0.4)-eOPN3-mScarlet-WPRE (#125712). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa(0.4)-eOPN3-mScarlet-WPRE plasmid DNA. CaMKIIa-driven expression of the optimized mosquito OPN3 rhodopsin in-frame with mScarlet. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.DepositorPromotershort version of αCamKinase II promoter (0.4kb)Available sinceJan. 8, 2025AvailabilityAcademic Institutions and Nonprofits only -
pAAV-CAG-DIO-HA-HCARD-P2A-mCitrine (AAV8)
Viral prep#228902-AAV8PurposeReady-to-use AAV8 particles produced from pAAV-CAG-DIO-HA-HCARD-P2A-mCitrine (#228902). In addition to the viral particles, you will also receive purified pAAV-CAG-DIO-HA-HCARD-P2A-mCitrine plasmid DNA. CAG-driven, Cre dependent expression of a peripherally restricted DREADD. These AAV preparations are suitable purity for injection into animals.DepositorPromoterChicken Beta ActinTagsmCitrineAvailable sinceOct. 8, 2025AvailabilityAcademic Institutions and Nonprofits only -
pMaCTag-P11
Plasmid#120022PurposeTemplate for C-terminal PCR tagging of mammalian genes (Puromycin selection) with mScarlet-iDepositorInsertmScarlet-i
UsePcr templateTagsmScarlet-iPromoterNoneAvailable sinceJan. 8, 2019AvailabilityAcademic Institutions and Nonprofits only -
pMRE-Tn7-146
Plasmid#118562PurposeminiTn7 plasmid to deliver constitutively expressed fluorescent protein genes in bacteriaDepositorInsertmCardinal
UseMinitn7 delivery vectorExpressionBacterialAvailable sinceNov. 26, 2018AvailabilityAcademic Institutions and Nonprofits only -
pMRE135
Plasmid#118489Purposebroad-host range plasmid to constitutively express fluorescent protein genes in bacteriaDepositorInsertmScarlet-I
ExpressionBacterialAvailable sinceNov. 19, 2018AvailabilityAcademic Institutions and Nonprofits onlyCited by -
pMRE-Tn5-155
Plasmid#118537PurposeminiTn5 plasmid to deliver constitutively expressed fluorescent protein genes in bacteriaDepositorInsertmScarlet-I
UseMinitn5 delivery vectorExpressionBacterialAvailable sinceNov. 26, 2018AvailabilityAcademic Institutions and Nonprofits onlyCited by